Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $74.97 USD
Change Today 0.00 / 0.00%
Volume 0.0
CHGCY On Other Exchanges
As of 8:10 PM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

Insiders at chugai pharmaceutic-unsp adr (CHGCY)

Name (Connections)Board RelationshipsTitleType of Board MemberAge
Osamu Nagayama 50 RelationshipsChairman and Chief Executive OfficerChief Executive Officer68
Tatsuro Kosaka 22 RelationshipsPresident, Chief Operating Officer and Representative DirectorPresident--
Yoshio Itaya 22 RelationshipsChief Financial Officer, Executive Vice President, General Manager of Finance Supervisory Division and DirectorChief Financial Officer--
Yutaka Tanaka 22 RelationshipsExecutive Vice President and DirectorSenior Key Executive--

Other Board Members on Board*

Name (Connections)Board RelationshipsType of Board MemberPrimary CompanyAge
Motoo Ueno 22 RelationshipsVice ChairmanChugai Pharmaceutical Co. Ltd.--
Henry Nordhoff 75 RelationshipsUnit ChairmanBanyan Biomarkers, Inc.73
Franz Humer Ph.D., MBA 148 RelationshipsMember of the Board of DirectorsPappas Ventures69
Victor Halberstadt 37 RelationshipsMember of Advisory BoardThe Goldman Sachs Group, Inc.--
Abraham Sofaer J.D. 39 RelationshipsMember of Advisory BoardRambus Inc.76
Yasuo Ikeda 22 RelationshipsMember of the Board of DirectorsChugai Pharmaceutical Co. Ltd.--
Arnold Levine Ph.D. 96 RelationshipsMember of Advisory BoardPMV Pharmaceuticals, Inc.75
Andrew von Eschenbach M.D. 51 RelationshipsMember of Advisory BoardPennsylvania Hospital73
Robert Ingram 207 RelationshipsMember of Advisory BoardJennerex Biotherapeutics, Inc.73
Andre Hoffmann A.C., D.E. 67 RelationshipsMember of Advisory BoardGivaudan SA57
Virginia Bottomley DL,PC,JP,MSc 42 RelationshipsMember of Advisory BoardOdgers Berndtson Group67
Sophie Kornowski-Bonnet 22 RelationshipsMember of the Board of DirectorsChugai Pharmaceutical Co. Ltd.--
Daniel O'Day 87 RelationshipsMember of the Board of DirectorsRoche Holding AG51
Sonosuke Kadonaga 59 RelationshipsMember of Advisory BoardKao Corporation63
Masayuki Oku 145 RelationshipsMember of the Board of DirectorsSumitomo Mitsui Financial Group, Inc.71
Shunji Yokoyama 22 RelationshipsMember of Audit CommitteeKasai Kogyo Co., Ltd.--
Kunitoshi Watanabe 22 RelationshipsMember of Audit CommitteeChugai Pharmaceutical Co. Ltd.--
Hisashi Hara 25 RelationshipsMember of Audit CommitteeChugai Pharmaceutical Co. Ltd.68
Michio Ishizuka 22 RelationshipsMember of Audit CommitteeChugai Pharmaceutical Co. Ltd.--
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CHGCY:US $74.97 USD 0.00

CHGCY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AbbVie Inc $63.98 USD -0.53
Eli Lilly & Co $83.19 USD -0.55
Hospira Inc $89.93 USD +0.01
Merck KGaA €85.19 EUR +0.106
Teva Pharmaceutical Industries Ltd $65.03 USD -0.17
View Industry Companies

Industry Analysis


Industry Average

Valuation CHGCY Industry Range
Price/Earnings 48.5x
Price/Sales 5.3x
Price/Book 4.1x
Price/Cash Flow 49.7x
TEV/Sales 4.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHUGAI PHARMACEUTIC-UNSP ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at